Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Peris

Showing results (151-160 of 532) with videos related to

Pageof 54
Sort By:
JAMA Dermatology|April 23, 2020
Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis BullosaAlfredo Piccerillo, Maya El Hachem, Rita De Vito, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2005
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trialKetty Peris, Elena Campione, Tamara Micantonio, et al.
Case Reports in Dermatological Medicine|June 28, 2024
Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic DermatitisNiccolò Gori, Eleonora De Luca, Andrea Chiricozzi, et al.
Human Mutation|February 7, 2007
Comprehensive evaluation of allele frequency differences of MC1R variants across populationsMeg R Gerstenblith, Alisa M Goldstein, Maria Concetta Fargnoli, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Efficacy and Safety of Imiquimod 3.75% from Lmax in Actinic Keratosis According to Fitzpatrick Skin TypeAgustin Alomar, Eggert Stockfleth, Thomas Dirschka, et al.
Pharmaceutics|October 28, 2023
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis SuppurativaDalma Malvaso, Laura Calabrese, Andrea Chiricozzi, et al.
International Journal of Dermatology|March 24, 2023
Drug survival of methotrexate and predictor factors for discontinuation in psoriasisGiacomo Caldarola, Eleonora De Luca, Marco Mariani, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2021
Erika V De Luca, Silvia Catapano, Laura Del Regno, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 3, 2021
Purple papules during anti-PD1 immunotherapy for metastatic melanomaErika V De Luca, Silvia Catapano, Laura Del Regno, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 27, 2003
Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of cutaneous hyperpigmentations in adult femalesClaudia Cotellessa, Ketty Peris, Maria Concetta Fargnoli, et al.
Pageof 54

Showing results (151-160 of 532) with videos related to

Sort By:
Pageof 54
JAMA Dermatology|April 23, 2020
Pembrolizumab for Treatment of a Patient With Multiple Cutaneous Squamous Cell Carcinomas and Recessive Dystrophic Epidermolysis BullosaAlfredo Piccerillo, Maya El Hachem, Rita De Vito, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|April 22, 2005
Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trialKetty Peris, Elena Campione, Tamara Micantonio, et al.
Case Reports in Dermatological Medicine|June 28, 2024
Successful Use of Dupilumab in the Treatment of Acquired Perforating Dermatosis Associated with Atopic DermatitisNiccolò Gori, Eleonora De Luca, Andrea Chiricozzi, et al.
Human Mutation|February 7, 2007
Comprehensive evaluation of allele frequency differences of MC1R variants across populationsMeg R Gerstenblith, Alisa M Goldstein, Maria Concetta Fargnoli, et al.
Journal of Drugs in Dermatology : JDD|March 9, 2016
Efficacy and Safety of Imiquimod 3.75% from Lmax in Actinic Keratosis According to Fitzpatrick Skin TypeAgustin Alomar, Eggert Stockfleth, Thomas Dirschka, et al.
Pharmaceutics|October 28, 2023
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis SuppurativaDalma Malvaso, Laura Calabrese, Andrea Chiricozzi, et al.
International Journal of Dermatology|March 24, 2023
Drug survival of methotrexate and predictor factors for discontinuation in psoriasisGiacomo Caldarola, Eleonora De Luca, Marco Mariani, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 16, 2021
Erika V De Luca, Silvia Catapano, Laura Del Regno, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 3, 2021
Purple papules during anti-PD1 immunotherapy for metastatic melanomaErika V De Luca, Silvia Catapano, Laura Del Regno, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 27, 2003
Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of cutaneous hyperpigmentations in adult femalesClaudia Cotellessa, Ketty Peris, Maria Concetta Fargnoli, et al.
Pageof 54